Madrigal Pharmaceuticals Inc (MDGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MDGL? Forum Prognose Aktiensplit

Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.77% 321.08	287.27	212.80	137.25	103.32
Operating Expenses	5.12% 380.69	401.24	260.00	216.56	164.08
Benefits Costs and Expenses	379.66	-	-	210.49	162.74
Costs And Expenses	5.38% 379.66	401.24	260.00	210.49	194.72
Operating Income/Loss	47.70% -59.61	-113.97	-47.20	-79.31	-67.00
Income/Loss From Continuing Operations Before Tax	120.39% -58.58	287.27	-42.28	-73.24	-59.42
Income/Loss From Continuing Operations After Tax	48.70% -58.58	-114.19	-42.28	-73.24	-59.42
Net Income/Loss	48.70% -58.58	-114.19	-42.28	-73.24	-59.42
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.23% 0.1726	22.48	22.21	22.09	0.2204
Diluted Average Shares	99.23% 0.1726	22.48	22.21	22.09	0.2204
Basic Earnings Per Share	50.20% -2.53	-5.08	-1.90	-3.32	-2.59
Diluted Earnings Per Share	50.20% -2.53	-5.08	-1.90	-3.32	-2.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-